Average Co-Inventor Count = 5.95
ph-index = 4
The patent ph-index is calculated by counting the number of publications for which an author has been cited by other authors at least that same number of times.
Company Filing History:
1. Janssen Pharmaceutica Nv (8 from 2,076 patents)
2. Ortho-mcneil Pharmaceutical Corp. (6 from 363 patents)
3. Millennium Pharmaceuticals Limited (1 from 850 patents)
4. Ortho-mcneil-janssen Pharmaceuticals, Inc. (1 from 1 patent)
15 patents:
1. 8673890 - 2,3-dihydro-1H-isoindol-1-imine derivatives useful as thrombin PAR-1 receptor antagonist
2. 8633322 - Alkynyl derivatives useful as DPP-1 inhibitors
3. 8481547 - Substituted benzothiazole and benzoxazole derivatives useful as inhibitors of DPP-1
4. 7855203 - Indazolyl-substituted pyrroline compounds as kinase inhibitors
5. 7759380 - Substituted pyrrolines as kinase inhibitors
6. 7629319 - Heteroaryl peptidomimetics as thrombin receptor antagonists
7. 7618945 - Heteroaryl peptidomimetics as thrombin receptor antagonists
8. 7608634 - Substituted pyrrolines as kinase inhibitors
9. 7329657 - Indazolyl-substituted pyrroline compounds as kinase inhibitors
10. 7304060 - Indazolyl-substituted pyrroline compounds as kinase inhibitors
11. 7232906 - Substituted pyrrolines as kinase inhibitors
12. 6943149 - Benzimidazolone peptidomimetics as thrombin receptor antagonists
13. 6849643 - Indazolyl-substituted pyrroline compounds as kinase inhibitors
14. 6828327 - Macroheterocylic compounds useful as kinase inhibitors
15. 6630451 - Benzimidazolone peptidometics as thrombin receptor antagonist